Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: J Allergy Clin Immunol. 2013 Nov 28;133(4):1092–1098. doi: 10.1016/j.jaci.2013.09.044

Table II.

Eligibility of Patients for Enrollment into the Retrospective PIDTC 6902 Protocol Study 2000 to 2009

Site rank number Total patients reviewed for eligibility Total eligible/enrolled Total not eligible
1 64 64 0
2 28 27 1
3 24 23 1
4 21 19 2
5 19 16 3
6 17 15 2
7 17 6 11
8 16 16 0
9 14 13 1
10 13 11 2
11 11 7 4
12 10 10 0
13 10 8 2
14 10 8 2
15 9 3 6
16 7 7 0
17 6 5 1
18 6 2 4
19 5 5 0
20 4 4 0
21 4 4 0
22 3 3 0
23 3 3 0
24 3 2 1
25 3 1 2
26 3 2 1
27 2 1 1
Totals 332 285 (86%) 47 (14%)

Note: 27 total sites are participating in the 6902 2000-2009 study (there are currently 33 sites participating in the PIDTC)